$TSOI Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune™ Company Intends to Initiate Clinical Trials using Novel "Multipronged" Attack on Coronavirus Pathology